Detection of bone metastases in thyroid cancer patients: Bone scintigraphy or F-FDG PET?

Nuclear Medicine Communications

Volumn 28, Issue 8, 2007, Pages 597-602

  Phan, Ha T T ^a   Jager, Pieter L ^a   Plukker, John T M ^a   Wolffenbuttel, Bruce H R ^b   Dierckx, Rudi A ^b   Links, Thera P ^b  

^a Departments of Nuclear Medicine and Molecular Imaging   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Bone metastases; Bone scintigraphy; Differentiated thyroid cancer; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BONE METASTASIS; BONE RADIOGRAPHY; BONE SCINTISCANNING; CANCER CYTODIAGNOSIS; CANCER PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY; THYROID CANCER;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; THYROID NEOPLASMS;

EID: 34447566078     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32822a0cb5     Document Type: Article

References (10)

1. Tickoo SK, Pittas AG, Adler M, Fazzari M, Larson SM, Robbins RJ, et al. Bone metastases from thyroid carcinoma. A histopathologic study with clinical correlates. Arch Pathol Lab Med 2000; 124:1440-1447.
2. Fogelman I, Cook G, Israel O, Wall van der H. Positron emission tomography and bone metastases. Semin Nucl Med 2005; 35:135-142.
3. Nakai T, Okuyama C, Kubota T, Yamada K, Ushijima Y, Taniike K, et al. Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer. Eur J Nucl Med Mol Imaging 2005; 32:1253-1258.
4. Cheran SK, Herndon 2nd JE, Patz Jr EF. Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer. Lung Cancer 2004; 44:317-325.
5. Uematsu T, Yuen S, Yukisawa S, Arimaki T, Morimoto N, Endo M, et al. Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer. AJR 2005; 18:1266-1273.
6. 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer. Ann Nucl Med 2005; 19:573-579.
7. 18F-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases. Anticancer Res 2000; 20:2189-2192.
8. Fogelman I. Osteoblastic bone metastases in breast cancer: is not seeing believing? Eur J Nucl Med Mol Imaging 2005; 32:1250-1252.
9. 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol 1998; 16:3375-3379.
10. Cook GJ, Fogelman I. The role of positron emission tomography in the management of bone metastases. Cancer 2000; 88:2927-3293.